Covid-19: ICMR revised strategy for testing in country

On Monday, The Indian Council of Medical Research (ICMR) has revised the strategy for testing coronavirus disease as the number of infected people crossed 1,00,000 mark today
The updated strategy proposes all symptomatic individuals who have recent history of travel tp abroad in the past 14 days to be tested. The strategy also says that test would also be conducted on all symptomatic contacts of laboratory confirmed cases, healthcare workers who are in the battlefield against Covid-19 and patients suffering from Severe Acute Respiatory Infection or SARI.

According to new ICMR testing strategy says, the high-risk contacts of a confirmed case should be tested once between day 5 and day 10 of coming into contact. All symptomatic patients with Influenza Like Illness (ILI) and patients who develop ILI symptoms should also be tested.

Dr Rajnikant Srivastava, the head of the Department of Research Management, Policy Planning and Communication at ICMR said, Till Friday, a total of 20,39,952 samples were tested in the country with 92,911 tests being conducted since Thursday 9 am.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India